Provectus Biopharmaceuticals Net Tangible Assets

Provectus Biopharmaceuticals (PVCT) currently reports a net tangible assets of $-6.7M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Provectus Biopharmaceuticals's net tangible assets history and peer comparisons.

Provectus Biopharmaceuticals's net tangible assets changed from $0 to $-6.7M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Provectus Biopharmaceuticals reported $-6.7M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-6.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Provectus Biopharmaceuticals, and consider following PVCT for alerts when major investors trade the stock.

Provectus Biopharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $-6.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PVCT with unrelated industries.